nemolizumab
搜索文档
Chugai Pharmaceutical (4519): Overseas results: Roche, Galderma2Q FY2026-20260723
摩根大通· 2026-07-23 19:15
J P M O R G A N Asia Pacific Equity Research 23 July 2026 Chugai Pharmaceutical (4519) Overseas results: Roche, Galderma 2Q FY2026 Roche and Galderma (both covered by Richard Vosser) announced 2Q (April- June) FY2026 results at 14:00 JST on July 23. Conference calls will be held at 21:00 by Roche and at 20:00 by Galderma. Chugai Pharmaceutical is due to announce its 2Q FY2026 results at 16:00 on July 24, followed by a conference call at 17:00. Among Roche's products, Hemlibra and Actemra both beat our estim ...